During the past decade, Consultants for Clinical Research conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 19 clinical trials were completed, i.e. on average, 57.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Consultants for Clinical Research" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Abbott" with 4 trials sponsored, "Bausch Health Americas, Inc." with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consultants for Clinical Research" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Consultants for Clinical Research" are "Crohn's Disease" (14 trials), "Ulcerative Colitis" (13 trials), "Colorectal Cancer" (4 trials), "Eosinophilic Esophagitis" (4 trials) and "Irritable Bowel Syndrome" (4 trials). Many other conditions were trialed in "Consultants for Clinical Research" in a lesser frequency.

Most popular intervention types in "Consultants for Clinical Research" are "Drug" (65 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Filgotinib" (4 trials), "Ribavirin" (3 trials), "CC-93538" (2 trials) and "Obeticholic Acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Consultants for Clinical Research" are 72 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Consultants for Clinical Research". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 45 completed trials in Consultants for Clinical Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Consultants for Clinical Research, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".